Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical timolol for small superficial infantile haemangioma
ACTRN12610001069044Phase 2Completed
- Sponsor
- Sydney Children's Hospital
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Capillary Haemangioma comparing Topical timolol with Placebo control (2 arms). Primary endpoint: Decrease in red colour at 24 weeks. Started Feb 2011; status: completed.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on ACTRN12610001069044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001069044.